from FOX News https://ift.tt/2XWWrm4
Pfizer begins Phase 2/3 study for COVID-19 oral antiviral in exposed adults
Pfizer initiated a Phase 2/3 study of an investigational oral antiviral with a low dose of ritonavir to prevent COVID-19 illness, the company announced Monday.
from FOX News https://ift.tt/2XWWrm4
from FOX News https://ift.tt/2XWWrm4
Related Posts:
FOX NEWS: Mark Levin: 'I'm disgusted with all the tyranny'- Nursing programs struggle to keep up amid a nationwide shortage of nurses
- FOX NEWS: Pregnant nurse that refused COVID vaccine on suspension: You feel 'disposable'
- FOX NEWS: Jesse Kelly: 'We are no longer one nation' because of COVID
- FOX NEWS: Nursing programs struggle to keep up amid a nationwide shortage of nurses
0 comments:
Post a Comment